Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Moodys
AstraZeneca
Dow

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Flupirtine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Flupirtine?

Flupirtine is an investigational drug.

There have been 4 clinical trials for Flupirtine. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2017.

The most common disease conditions in clinical trials are Multiple Sclerosis, Neoplasm Metastasis, and Sclerosis. The leading clinical trial sponsors are Bayer, Charite University, Berlin, Germany, and Ludwig-Maximilians - University of Munich.

There are four hundred and sixty-seven US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Flupirtine
TitleSponsorPhase
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid TumorAlphacait, LLCPhase 2
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid TumorHaining Health-Coming Biotech Co., Ltd.Phase 2
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in VivoLudwig-Maximilians - University of MunichPhase 1

See all Flupirtine clinical trials

Clinical Trial Summary for Flupirtine

Top disease conditions for Flupirtine
Top clinical trial sponsors for Flupirtine

See all Flupirtine clinical trials

US Patents for Flupirtine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Flupirtine ⤷  Try it Free Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases Halozyme, Inc. (San Diego, CA) ⤷  Try it Free
Flupirtine ⤷  Try it Free Engineered nucleic acids and methods of use thereof ModernaTX, Inc. (Cambridge, MA) ⤷  Try it Free
Flupirtine ⤷  Try it Free Polynucleotides encoding immune modulating polypeptides ModernaTX, Inc. (Cambridge, MA) ⤷  Try it Free
Flupirtine ⤷  Try it Free Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same Platform Brightworks Two, Ltd. (Houston, TX) ⤷  Try it Free
Flupirtine ⤷  Try it Free Nuclear transport modulators and uses thereof Biogen MA Inc. (Cambridge, MA) ⤷  Try it Free
Flupirtine ⤷  Try it Free Benzazole compounds and methods for making and using the compounds Rigel Pharmaceuticals, Inc. (South San Francisco, CA) ⤷  Try it Free
Flupirtine ⤷  Try it Free Adjunct material to provide controlled drug elution Ethicon LLC (Guaynabo, PR) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Flupirtine

Drugname Country Document Number Estimated Expiration Related US Patent
Flupirtine Austria AT448323 2023-03-05 ⤷  Try it Free
Flupirtine Australia AU2004218354 2023-03-05 ⤷  Try it Free
Flupirtine Australia AU2006216545 2023-03-05 ⤷  Try it Free
Flupirtine Australia AU2009245838 2023-03-05 ⤷  Try it Free
Flupirtine Australia AU2013202475 2023-03-05 ⤷  Try it Free
Flupirtine Brazil BRPI0408116 2023-03-05 ⤷  Try it Free
Flupirtine Brazil BRPI0608314 2023-03-05 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Baxter
Moodys
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.